Detalhe da pesquisa
1.
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(1): 92-120, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040721
2.
New NCCN Guidelines for Vulvar Cancer.
J Natl Compr Canc Netw
; 14(5 Suppl): 656-8, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226506
3.
NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care.
J Natl Compr Canc Netw
; 14(8): 961-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27496112
4.
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.
Gynecol Oncol
; 139(1): 17-22, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216729
5.
Cervical Cancer, Version 2.2015.
J Natl Compr Canc Netw
; 13(4): 395-404; quiz 404, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870376
6.
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.
J Natl Compr Canc Netw
; 13(11): 1321-31, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553763
7.
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
N Engl J Med
; 365(26): 2473-83, 2011 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22204724
8.
Uterine neoplasms, version 1.2014.
J Natl Compr Canc Netw
; 12(2): 248-80, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586086
9.
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 128(3): 573-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219660
10.
Cervical cancer.
J Natl Compr Canc Netw
; 11(3): 320-43, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23486458
11.
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
J Clin Oncol
; 41(25): 4077-4083, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643542
12.
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Cancer
; 117(16): 3731-40, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21815133
13.
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.
Gynecol Oncol
; 119(3): 484-90, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20870280
14.
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 113(3): 341-7, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19272639
15.
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
J Clin Oncol
; 37(26): 2317-2328, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216226
16.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
J Clin Oncol
; 21(17): 3194-200, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12860964
17.
Cervical cancer.
J Natl Compr Canc Netw
; 8(12): 1388-416, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21147903
18.
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.
J Clin Oncol
; 32(12): 1210-7, 2014 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24637999
19.
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.
Magn Reson Imaging
; 30(9): 1291-300, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22795929
20.
Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
Gynecol Oncol
; 104(1): 114-9, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16959305